vs
太平洋生物科学（ASMB）与美国运通（AXP）财务数据对比。点击上方公司名可切换其他公司
美国运通的季度营收约是太平洋生物科学的1.8倍（$18.9M vs $10.8M），美国运通净利率更高（15.7% vs -85.2%，领先100.9%），太平洋生物科学同比增速更快（57.6% vs 11.4%）
该公司是一家成立于2004年的美国生物科技企业，主要研发生产基因测序相关设备，同时也开展新型实时生物观测技术相关业务。目前拥有两大核心测序平台，分别是基于零模波导特性的单分子实时测序平台，以及结合天然核苷酸无痕连接技术的结合测序平台。
美国运通是全球知名的支付服务提供商，主营签账卡、信用卡产品及旅行相关服务，下设全球消费者服务、全球商业服务、全球商户与网络服务三大业务板块，还提供支付融资、网络服务、应付账款费用管理、旅行生活服务等多元解决方案。
ASMB vs AXP — 直观对比
营收规模更大
AXP
是对方的1.8倍
$10.8M
营收增速更快
ASMB
高出46.2%
11.4%
净利率更高
AXP
高出100.9%
-85.2%
损益表 — Q3 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $10.8M | $18.9M |
| 净利润 | $-9.2M | $3.0M |
| 毛利率 | — | — |
| 营业利润率 | -100.9% | — |
| 净利率 | -85.2% | 15.7% |
| 营收同比 | 57.6% | 11.4% |
| 净利润同比 | 4.3% | 15.0% |
| 每股收益（稀释后） | $-0.72 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASMBAXP
| Q1 26 | — | $18.9M | ||
| Q4 25 | — | $10.9B | ||
| Q3 25 | $10.8M | $10.4B | ||
| Q2 25 | $9.6M | $10.3B | ||
| Q1 25 | $9.4M | $9.6B | ||
| Q4 24 | $7.4M | $10.0B | ||
| Q3 24 | $6.8M | $9.7B | ||
| Q2 24 | $8.5M | $9.8B |
净利润ASMBAXP
| Q1 26 | — | $3.0M | ||
| Q4 25 | — | $2.5B | ||
| Q3 25 | $-9.2M | $2.9B | ||
| Q2 25 | $-10.2M | $2.9B | ||
| Q1 25 | $-8.8M | $2.6B | ||
| Q4 24 | — | $2.2B | ||
| Q3 24 | $-9.6M | $2.5B | ||
| Q2 24 | $-11.2M | $3.0B |
营业利润率ASMBAXP
| Q1 26 | — | — | ||
| Q4 25 | — | 28.2% | ||
| Q3 25 | -100.9% | 36.7% | ||
| Q2 25 | -115.2% | 34.4% | ||
| Q1 25 | -105.5% | 34.6% | ||
| Q4 24 | — | 27.7% | ||
| Q3 24 | -160.1% | 33.0% | ||
| Q2 24 | -143.0% | 38.6% |
净利率ASMBAXP
| Q1 26 | — | 15.7% | ||
| Q4 25 | — | 22.5% | ||
| Q3 25 | -85.2% | 27.9% | ||
| Q2 25 | -105.9% | 28.0% | ||
| Q1 25 | -93.6% | 26.8% | ||
| Q4 24 | — | 21.8% | ||
| Q3 24 | -140.4% | 25.8% | ||
| Q2 24 | -130.7% | 30.7% |
每股收益（稀释后）ASMBAXP
| Q1 26 | — | — | ||
| Q4 25 | — | $3.52 | ||
| Q3 25 | $-0.72 | $4.14 | ||
| Q2 25 | $-1.33 | $4.08 | ||
| Q1 25 | $-1.17 | $3.64 | ||
| Q4 24 | — | $3.04 | ||
| Q3 24 | $-1.51 | $3.49 | ||
| Q2 24 | $-1.98 | $4.15 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $22.5M | — |
| 总债务越低越好 | — | $60.4M |
| 股东权益账面价值 | $182.7M | $34.0M |
| 总资产 | $240.0M | $308.9M |
| 负债/权益比越低杠杆越低 | — | 1.78× |
8季度趋势，按日历期对齐
现金及短期投资ASMBAXP
| Q1 26 | — | — | ||
| Q4 25 | — | $742.0M | ||
| Q3 25 | $22.5M | $1.3B | ||
| Q2 25 | $24.0M | $197.0M | ||
| Q1 25 | $23.4M | $261.0M | ||
| Q4 24 | $38.3M | $221.0M | ||
| Q3 24 | $28.5M | $120.0M | ||
| Q2 24 | $19.2M | $188.0M |
总债务ASMBAXP
| Q1 26 | — | $60.4M | ||
| Q4 25 | — | $56.4B | ||
| Q3 25 | — | $57.8B | ||
| Q2 25 | — | $58.2B | ||
| Q1 25 | — | $51.2B | ||
| Q4 24 | — | $49.7B | ||
| Q3 24 | — | $53.5B | ||
| Q2 24 | — | $51.5B |
股东权益ASMBAXP
| Q1 26 | — | $34.0M | ||
| Q4 25 | — | $33.5B | ||
| Q3 25 | $182.7M | $32.4B | ||
| Q2 25 | $18.1M | $32.3B | ||
| Q1 25 | $27.1M | $31.2B | ||
| Q4 24 | $33.4M | $30.3B | ||
| Q3 24 | $26.0M | $29.7B | ||
| Q2 24 | $34.7M | $29.5B |
总资产ASMBAXP
| Q1 26 | — | $308.9M | ||
| Q4 25 | — | $300.1B | ||
| Q3 25 | $240.0M | $297.6B | ||
| Q2 25 | $80.8M | $295.6B | ||
| Q1 25 | $99.0M | $282.2B | ||
| Q4 24 | $119.2M | $271.5B | ||
| Q3 24 | $100.3M | $271.0B | ||
| Q2 24 | $115.3M | $272.2B |
负债/权益比ASMBAXP
| Q1 26 | — | 1.78× | ||
| Q4 25 | — | 1.68× | ||
| Q3 25 | — | 1.78× | ||
| Q2 25 | — | 1.80× | ||
| Q1 25 | — | 1.64× | ||
| Q4 24 | — | 1.64× | ||
| Q3 24 | — | 1.80× | ||
| Q2 24 | — | 1.74× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-15.1M | — |
| 自由现金流经营现金流 - 资本支出 | $-15.2M | — |
| 自由现金流率自由现金流/营收 | -140.7% | — |
| 资本支出强度资本支出/营收 | 0.4% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASMBAXP
| Q1 26 | — | — | ||
| Q4 25 | — | $3.1B | ||
| Q3 25 | $-15.1M | $6.2B | ||
| Q2 25 | $-16.8M | $4.4B | ||
| Q1 25 | $-23.4M | $4.8B | ||
| Q4 24 | $-51.1M | $5.8B | ||
| Q3 24 | $-15.2M | $-1.8B | ||
| Q2 24 | $-17.1M | $4.5B |
自由现金流ASMBAXP
| Q1 26 | — | — | ||
| Q4 25 | — | $2.3B | ||
| Q3 25 | $-15.2M | $5.6B | ||
| Q2 25 | — | $3.7B | ||
| Q1 25 | — | $4.3B | ||
| Q4 24 | $-51.1M | $5.3B | ||
| Q3 24 | — | $-2.3B | ||
| Q2 24 | $-17.1M | $4.0B |
自由现金流率ASMBAXP
| Q1 26 | — | — | ||
| Q4 25 | — | 21.4% | ||
| Q3 25 | -140.7% | 53.6% | ||
| Q2 25 | — | 36.3% | ||
| Q1 25 | — | 45.0% | ||
| Q4 24 | -695.2% | 53.1% | ||
| Q3 24 | — | -23.3% | ||
| Q2 24 | -200.6% | 40.4% |
资本支出强度ASMBAXP
| Q1 26 | — | — | ||
| Q4 25 | — | 6.6% | ||
| Q3 25 | 0.4% | 6.3% | ||
| Q2 25 | 0.0% | 6.0% | ||
| Q1 25 | 0.0% | 4.5% | ||
| Q4 24 | 0.4% | 5.0% | ||
| Q3 24 | 0.0% | 4.7% | ||
| Q2 24 | 0.2% | 5.8% |
现金转化率ASMBAXP
| Q1 26 | — | — | ||
| Q4 25 | — | 1.25× | ||
| Q3 25 | — | 2.15× | ||
| Q2 25 | — | 1.51× | ||
| Q1 25 | — | 1.84× | ||
| Q4 24 | — | 2.66× | ||
| Q3 24 | — | -0.72× | ||
| Q2 24 | — | 1.50× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASMB
暂无分部数据
AXP
| Discount revenue | $9.5M | 50% |
| Other | $8.9M | 47% |
| Deposits with banks and other | $512.0K | 3% |
